149 related articles for article (PubMed ID: 29540182)
1. Relationship between mismatch repair immunophenotype and long-term survival in patients with resected periampullary adenocarcinoma.
Heby M; Lundgren S; Nodin B; Elebro J; Eberhard J; Jirström K
J Transl Med; 2018 Mar; 16(1):66. PubMed ID: 29540182
[TBL] [Abstract][Full Text] [Related]
2. The clinical importance of tumour-infiltrating macrophages and dendritic cells in periampullary adenocarcinoma differs by morphological subtype.
Lundgren S; Karnevi E; Elebro J; Nodin B; Karlsson MCI; Eberhard J; Leandersson K; Jirström K
J Transl Med; 2017 Jul; 15(1):152. PubMed ID: 28673320
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma.
Elebro J; Heby M; Gaber A; Nodin B; Jonsson L; Fristedt R; Uhlén M; Jirström K; Eberhard J
J Transl Med; 2014 Oct; 12():289. PubMed ID: 25323550
[TBL] [Abstract][Full Text] [Related]
4. Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer.
Elebro J; Ben Dror L; Heby M; Nodin B; Jirström K; Eberhard J
Acta Oncol; 2016; 55(3):286-96. PubMed ID: 26362587
[TBL] [Abstract][Full Text] [Related]
5. DNA mismatch repair deficiency but not ARID1A loss is associated with prognosis in small intestinal adenocarcinoma.
González I; Goyal B; Xia MD; Pai RK; Ma C
Hum Pathol; 2019 Mar; 85():18-26. PubMed ID: 30381262
[TBL] [Abstract][Full Text] [Related]
6. Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy.
Kim JE; Hong YS; Kim HJ; Kim KP; Lee JL; Park SJ; Lim SB; Park IJ; Kim CW; Yoon YS; Yu CS; Kim JC; Hoon KJ; Kim TW
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S630-7. PubMed ID: 26271397
[TBL] [Abstract][Full Text] [Related]
7. Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes.
Williams DS; Mouradov D; Jorissen RN; Newman MR; Amini E; Nickless DK; Teague JA; Fang CG; Palmieri M; Parsons MJ; Sakthianandeswaren A; Li S; Ward RL; Hawkins NJ; Faragher I; Jones IT; Gibbs P; Sieber OM
Gut; 2019 Mar; 68(3):465-474. PubMed ID: 29382774
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma.
Heby M; Elebro J; Nodin B; Jirström K; Eberhard J
BMC Clin Pathol; 2015; 15():10. PubMed ID: 26028992
[TBL] [Abstract][Full Text] [Related]
9. Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1, 2 and 3 in Periampullary Adenocarcinoma.
Elebro J; Heby M; Warfvinge CF; Nodin B; Eberhard J; Jirström K
PLoS One; 2016; 11(4):e0153533. PubMed ID: 27070783
[TBL] [Abstract][Full Text] [Related]
10. Quantitative, qualitative and spatial analysis of lymphocyte infiltration in periampullary and pancreatic adenocarcinoma.
Lundgren S; Elebro J; Heby M; Nodin B; Leandersson K; Micke P; Jirström K; Mezheyeuski A
Int J Cancer; 2020 Jun; 146(12):3461-3473. PubMed ID: 32129882
[TBL] [Abstract][Full Text] [Related]
11. The Prognostic Impact of NK/NKT Cell Density in Periampullary Adenocarcinoma Differs by Morphological Type and Adjuvant Treatment.
Lundgren S; Warfvinge CF; Elebro J; Heby M; Nodin B; Krzyzanowska A; Bjartell A; Leandersson K; Eberhard J; Jirström K
PLoS One; 2016; 11(6):e0156497. PubMed ID: 27275582
[TBL] [Abstract][Full Text] [Related]
12. Association of Histopathologic Phenotype of Periampullary Adenocarcinomas With Survival.
Williams JL; Chan CK; Toste PA; Elliott IA; Vasquez CR; Sunjaya DB; Swanson EA; Koo J; Hines OJ; Reber HA; Dawson DW; Donahue TR
JAMA Surg; 2017 Jan; 152(1):82-88. PubMed ID: 27732711
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.
André T; de Gramont A; Vernerey D; Chibaudel B; Bonnetain F; Tijeras-Raballand A; Scriva A; Hickish T; Tabernero J; Van Laethem JL; Banzi M; Maartense E; Shmueli E; Carlsson GU; Scheithauer W; Papamichael D; Möehler M; Landolfi S; Demetter P; Colote S; Tournigand C; Louvet C; Duval A; Fléjou JF; de Gramont A
J Clin Oncol; 2015 Dec; 33(35):4176-87. PubMed ID: 26527776
[TBL] [Abstract][Full Text] [Related]
14. Predictors of long-term survival after pancreaticoduodenectomy for peri-ampullary adenocarcinoma: A retrospective study of 5-year survivors.
El Nakeeb A; El Sorogy M; Ezzat H; Said R; El Dosoky M; Abd El Gawad M; Elsabagh AM; El Hanafy E
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):443-449. PubMed ID: 30126828
[TBL] [Abstract][Full Text] [Related]
15. Perioperative Chemotherapy Could Not Improve the Prognosis of Gastric Cancer Patients With Mismatch Repair Deficiency: A Multicenter, Real-World Study.
Zhao L; Fu Y; Niu P; Zhang F; Jiao F; Zhou X; Wu Z; Wang W; Luan X; Han X; He M; Guan Q; Li Y; Zhao D; Gao J; Chen Y
Oncologist; 2023 Oct; 28(10):e891-e901. PubMed ID: 37104872
[TBL] [Abstract][Full Text] [Related]
16. Mutational Landscape in Resected Periampullary Adenocarcinoma: Relationship With Morphology and Clinical Outcome.
Lundgren S; Hau SO; Elebro J; Heby M; Karnevi E; Nodin B; Eberhard J; Holm K; Staaf J; Jönsson GB; Jirström K
JCO Precis Oncol; 2019; 3():. PubMed ID: 32914025
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of the polymeric immunoglobulin receptor in pancreatic and periampullary adenocarcinoma signifies tumour progression and poor prognosis.
Fristedt R; Elebro J; Gaber A; Jonsson L; Heby M; Yudina Y; Nodin B; Uhlén M; Eberhard J; Jirström K
PLoS One; 2014; 9(11):e112728. PubMed ID: 25397670
[TBL] [Abstract][Full Text] [Related]
18. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
[TBL] [Abstract][Full Text] [Related]
19. Immunohistological evaluation of mismatch repair deficiency in pancreatic ductal adenocarcinoma treated with surgical resection.
Otsuka H; Murakami Y; Uemura K; Kondo N; Nakagawa N; Okada K; Seo S; Takahashi S
J Hepatobiliary Pancreat Sci; 2020 Jul; 27(7):421-428. PubMed ID: 32219999
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of the relationship of DNA mismatch repair with clinicopathologic features and prognosis of colon cancer].
Qin Q; Ying J; Lyu N; Guo L; Zhi W; Zhou A; Wang J
Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):591-6. PubMed ID: 26714599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]